BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8395681)

  • 1. Biological and biochemical activity of E7 genes of the cutaneous human papillomavirus type 5 and 8.
    Yamashita T; Segawa K; Fujinaga Y; Nishikawa T; Fujinaga K
    Oncogene; 1993 Sep; 8(9):2433-41. PubMed ID: 8395681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ability of the HPV16 E7 protein to bind RB and induce DNA synthesis is not sufficient for efficient transforming activity in NIH3T3 cells.
    Banks L; Edmonds C; Vousden KH
    Oncogene; 1990 Sep; 5(9):1383-9. PubMed ID: 2216461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of immortalizing activity of a human papillomavirus type 16 variant DNA with a mutation in the E2 gene isolated from normal human cervical keratinocytes.
    Storey A; Greenfield I; Banks L; Pim D; Crook T; Crawford L; Stanley M
    Oncogene; 1992 Mar; 7(3):459-65. PubMed ID: 1312701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional analysis of human papillomavirus type 16 E7 by complementation with adenovirus E1A mutants.
    Davies RC; Vousden KH
    J Gen Virol; 1992 Aug; 73 ( Pt 8)():2135-9. PubMed ID: 1322963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional similarity between HPV16E7, SV40 large T and adenovirus E1a proteins.
    Vousden KH; Jat PS
    Oncogene; 1989 Feb; 4(2):153-8. PubMed ID: 2538790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic heterogeneity among human papillomaviruses (HPV) associated with epidermodysplasia verruciformis: evidence for multiple allelic forms of HPV5 and HPV8 E6 genes.
    Deau MC; Favre M; Orth G
    Virology; 1991 Oct; 184(2):492-503. PubMed ID: 1653484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The p53 tumor suppressor gene and gene product.
    Levine AJ
    Princess Takamatsu Symp; 1989; 20():221-30. PubMed ID: 2488233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of human papillomavirus type 16 open reading frame E7 immortalizing function in rat embryo fibroblast cells.
    Chesters PM; Vousden KH; Edmonds C; McCance DJ
    J Gen Virol; 1990 Feb; 71 ( Pt 2)():449-53. PubMed ID: 2155297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses.
    Heck DV; Yee CL; Howley PM; Münger K
    Proc Natl Acad Sci U S A; 1992 May; 89(10):4442-6. PubMed ID: 1316608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus E1A-p105(Rb) protein interactions play a direct role in the initiation but not the maintenance of the rodent cell transformed phenotype.
    Nielsch U; Fognani C; Babiss LE
    Oncogene; 1991 Jun; 6(6):1031-6. PubMed ID: 2067843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumorigenic transformation of primary rat embryonal fibroblasts by human papillomavirus type 8 E7 gene in collaboration with the activated H-ras gene.
    Nishikawa T; Yamashita T; Yamada T; Kobayashi H; Ohkawara A; Fujinaga K
    Jpn J Cancer Res; 1991 Dec; 82(12):1340-3. PubMed ID: 1663918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The region of the HPV E7 oncoprotein homologous to adenovirus E1a and Sv40 large T antigen contains separate domains for Rb binding and casein kinase II phosphorylation.
    Barbosa MS; Edmonds C; Fisher C; Schiller JT; Lowy DR; Vousden KH
    EMBO J; 1990 Jan; 9(1):153-60. PubMed ID: 2153075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [HPV16 participates in progressive transformation of normal epidermal cells].
    Yasumoto S
    Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 2):549-61. PubMed ID: 2539784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular proteins that are targetted by DNA tumor viruses for transformation.
    Dyson N; Buchkovich K; Whyte P; Harlow E
    Princess Takamatsu Symp; 1989; 20():191-8. PubMed ID: 2488232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced ras oncogene mediated cell transformation and tumorigenesis by adenovirus 2 mutants lacking the C-terminal region of E1a protein.
    Subramanian T; La Regina M; Chinnadurai G
    Oncogene; 1989 Apr; 4(4):415-20. PubMed ID: 2524023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reintroduction of a normal retinoblastoma gene into retinoblastoma and osteosarcoma cells inhibits the replication associated function of SV40 large T antigen.
    Uzvolgyi E; Classon M; Henriksson M; Huang HJ; Szekely L; Lee WH; Klein G; Sumegi J
    Cell Growth Differ; 1991 Jun; 2(6):297-303. PubMed ID: 2064998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single amino acid substitutions in "low-risk" human papillomavirus (HPV) type 6 E7 protein enhance features characteristic of the "high-risk" HPV E7 oncoproteins.
    Sang BC; Barbosa MS
    Proc Natl Acad Sci U S A; 1992 Sep; 89(17):8063-7. PubMed ID: 1325643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergism between pairs of immortalizing genes in transformation assays of rat embryo fibroblasts.
    Peacock JW; Matlashewski GJ; Benchimol S
    Oncogene; 1990 Dec; 5(12):1769-74. PubMed ID: 2178238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The full-length E6 protein of human papillomavirus type 16 has transforming and trans-activating activities and cooperates with E7 to immortalize keratinocytes in culture.
    Sedman SA; Barbosa MS; Vass WC; Hubbert NL; Haas JA; Lowy DR; Schiller JT
    J Virol; 1991 Sep; 65(9):4860-6. PubMed ID: 1651408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus type 16 E7 protein inhibits DNA binding by the retinoblastoma gene product.
    Stirdivant SM; Huber HE; Patrick DR; Defeo-Jones D; McAvoy EM; Garsky VM; Oliff A; Heimbrook DC
    Mol Cell Biol; 1992 May; 12(5):1905-14. PubMed ID: 1314947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.